Skip to main content

Table 3 Overall Survival (OS) and Progression free survival (PFS). Univariate regression

From: Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma

  p-value (OS) p-value (PFS)
Sex 0.24 0.23
Age 0.29 0.31
EOR at diagnosis 0.511 0.42
MGMT 0.14 0.11
Target Volume 0.87 0.96
IDH1 0.37 0.48
KPS 0.38 0.32
Treatment 0.01 0.004
  1. KPS karnofsky performancs status, IDH isocitrate dehydrogenase, MGMT methylguanine-DNA methyltransferase, EOR extension of resection